GOED also suggested certain populations should consume higher levels of EPA and DHA per day, such as pregnant and lactating women or people with high blood pressure.
Photo © iStockphoto.com/Gubcio
Despite widespread consensus among global health organizations that EPA and DHA omega-3 fatty acids play a key role in a complete diet, the actual amount of recommended daily omega-3 intake varies wildly from country to country. For instance, for healthy adults, the European Food Safety Authority (EFSA) recommends 250 mg EPA and DHA per day, Russia’s Customs Union Commission recommends 600 mg EPA and 700 mg DHA per day, and the USDA has yet to issue a specific recommendation amount.
Following years of discussion, the Global Organization of EPA and DHA Omega-3s (GOED; Salt Lake City, UT) has issued its own EPA and DHA intake recommendations. GOED now recommends healthy adults consume 500 mg of EPA and DHA per day to lower the risk of coronary heart disease.
Additionally, GOED issued specific recommendations for certain populations, such as pregnant and lactating women (200 additional mg/day of DHA on top of the 500 mg/day recommendation) and for those seeking a secondary prevention of coronary heart disease (1000 mg/day of EPA and DHA). For additional health conditions, such as high blood pressure or triglycerides, GOED recommends an EPA and DHA intake of greater than 1 g/day.
Read more:
New Breakthroughs in Omega-3 Research
Omega-3 Intake Linked with Reduced Depression Symptoms
Supplements for Seniors: New Research
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.